Your browser doesn't support javascript.
loading
Dasatinib plus prednisone as induction and consolidation for adults with Ph-positive acute lymphoblastic leukaemia: A single-arm, multicentre, phase 2 trial.
Xie, Mixue; Lu, Ying; Ouyang, Guifang; Li, Xueying; Shi, Ting; Yang, Min; Le, Jing; Hu, Huixian; Zhang, Li; Feng, Weiying; Meng, Haitao; Mai, Wenyuan; Wei, Juying; Qian, Jiejing; Xu, Gaixiang; Yang, Chunmei; Zhou, De; Lin, Yin; Qian, Suying; Kuang, Yuemin; Zhang, Liming; Zhu, Weiguo; Yao, Guoli; Wu, Gongqiang; Hu, Shao; Huang, Xin; Wang, Yungui; Tong, Hongyan; Jin, Jie; Zhu, Hong-Hu.
Afiliação
  • Xie M; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Lu Y; Department of Hematology, Yinzhou Hospital Affiliated to Medical School of Ningbo University, Ningbo, China.
  • Ouyang G; Department of Hematology, Ningbo Hospital of Zhejiang University, Ningbo, China.
  • Li X; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Shi T; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Yang M; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Le J; Department of Hematology, Ningbo Medical Center Lihuili Hospital, Ningbo, China.
  • Hu H; Department of Hematology, Jinhua Municipal Central Hospital Medical Group, Jinhua, China.
  • Zhang L; Department of Hematology, Taizhou Hospital of Zhejiang Province, Taizhou, China.
  • Feng W; Department of Hematology, Shaoxing People's Hospital, Shaoxing, China.
  • Meng H; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Mai W; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Wei J; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Qian J; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Xu G; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Yang C; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhou; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Lin Y; Department of Hematology and Oncology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Zhejiang, China.
  • Qian S; Department of Hematology, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
  • Kuang Y; Department of Hematology, Jinhua People's Hospital, Jinhua, China.
  • Zhang L; Department of Hematology, Zhuji People's Hospital, Shaoxing, China.
  • Zhu W; Department of Hematology, Shaoxing Second Hospital, Shaoxing, China.
  • Yao G; Department of Hematology, The First People's Hospital of Linping District, Hangzhou, China.
  • Wu G; Department of Hematology, Dongyang Hospital Affiliated to Wenzhou Medical University, Jinhua, China.
  • Hu S; Department of Hematology and Oncology, The First Hospital of Ninghai County, Ningbo, China.
  • Huang X; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Wang Y; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Tong H; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Jin J; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China.
  • Zhu HH; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China.
Br J Haematol ; 202(6): 1119-1126, 2023 09.
Article em En | MEDLINE | ID: mdl-37434414
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China